These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26170788)

  • 1. Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child.
    Yapici AK; Fidanci MK; Kilic S; Balamtekin N; Mutluay Arslan M; Yavuz ST; Kalman S
    Ann Burns Fire Disasters; 2014 Sep; 27(3):121-5. PubMed ID: 26170788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
    Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
    Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications.
    Bermeo-Ovalle A
    Epilepsy Curr; 2019; 19(2):96-98. PubMed ID: 30955419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens - Johnson Syndrome Induced by Combination of Lamotrigine and Valproic Acid in a 9-Year-Old Boy.
    Maduemem K; Vatca A; O'Neill T; Buckley D
    Ir Med J; 2017 Jun; 110(6):586. PubMed ID: 28952676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
    Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R
    Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid.
    Kocak S; Girisgin SA; Gul M; Cander B; Kaya H; Kaya E
    Am J Clin Dermatol; 2007; 8(2):107-11. PubMed ID: 17428116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
    Kim HK; Kim DY; Bae EK; Kim DW
    J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
    Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
    Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome induced by a combination of lamotrigine and valproic acid.
    Kavitha S; Anbuchelvan T; Mahalakshmi V; Sathya R; Sabarinath TR; Gururaj N; Kalaivani S
    J Pharm Bioallied Sci; 2015 Aug; 7(Suppl 2):S756-8. PubMed ID: 26538961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine induced toxic epidermal necrolysis: A case report.
    Kc KK; Limbu T; Maskay SS; Bhasima A; Acharya SP
    Ann Med Surg (Lond); 2020 Dec; 60():468-470. PubMed ID: 33294176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea.
    Park CS; Kang DY; Kang MG; Kim S; Ye YM; Kim SH; Park HK; Park JW; Nam YH; Yang MS; Jee YK; Jung JW; Kim SH; Kim CW; Kim MY; Kim JH; Lee J; Lee JG; Kim SH; La HO; Kim MH; Park SJ; Koh YI; Lee SM; Kwon YE; Jin HJ; Kim HK; Kang HR; Choi JH;
    Allergy Asthma Immunol Res; 2019 Sep; 11(5):709-722. PubMed ID: 31332981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine-induced severe cutaneous adverse reactions.
    Schlienger RG; Shapiro LE; Shear NH
    Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine-induced severe cutaneous adverse reaction: Update data from 1999-2014.
    Wang XQ; Lv B; Wang HF; Zhang X; Yu SY; Huang XS; Zhang JT; Tian CL; Lang SY
    J Clin Neurosci; 2015 Jun; 22(6):1005-11. PubMed ID: 25913750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis due to concomitant use of lamotrigine and valproic Acid.
    Kaur S; Dogra A
    Indian J Dermatol; 2013 Sep; 58(5):406. PubMed ID: 24082198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.
    Ordoñez L; Salgueiro E; Jimeno FJ; Manso G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2732-7. PubMed ID: 26221907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
    Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
    Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk].
    Gómez-Criado MS; Ayani I; León-Colombo T; Ramos ML; Reneses MJ
    Rev Neurol; 2004 Jun 1-15; 38(11):1056-60. PubMed ID: 15202085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.